Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 Apr 2005

Backmund Markus, Reimer Jens, Meyer Kirsten, Gerlach J Tilman, Zachoval Reinhart

Abstract excerpt

Injection drug users (IDUs) are the largest group of persons infected with hepatitis C virus (HCV), with a prevalence of 50%-90%. The transmission of HCV is not the effect of the drug injected but of sharing contaminated equipment. For the sake of prevention, we have to know which factors are more likely to lead to HCV seroconversion and which particular situations and environments are risk factors for equipment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Delivery of Health Care
Share to Germany

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Mental Disorders

Share to Methadone

Share to Narcotics

Share to Serologic Tests

Share to Substance Abuse, Intravenous

Source

Identifiers

PMID: 15768343
DOI: 10.1086/427475

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.PMID 15768343Read ↗

Prevalence and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: a cross sectional studySemantic proximity Read ↗

Coinfection with HIV and hepatitis C virus among injection drug users in southern China.Semantic proximity Read ↗

Hepatitis C virus infection among drug addicts in Italy.Semantic proximity Read ↗

Prevalence of hepatitis C virus infection and associated factors among male illicit drug users in Cuiabá, Mato Grosso, Brazil.Semantic proximity Read ↗

Hepatitis C infection among intravenous drug users attending therapy programs in CyprusSemantic proximity Read ↗

Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.Semantic proximity Read ↗

Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.Semantic proximity Read ↗

Infection with hepatitis C virus among intravenous-drug users: prevalence, genotypes and risk-factor-associated behaviour patterns in Thailand.Semantic proximity Read ↗

Prevalence of HCV infection and associated factors among illicit drug users in Breves, State of Pará, northern Brazil.Semantic proximity Read ↗

Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil.Semantic proximity Read ↗

Epidemiological aspects of HCV infection in non-injecting drug users in the Brazilian state of Pará, eastern Amazon.Semantic proximity Read ↗

Characteristics of chronic hepatitis C among intravenous drug users: a comparative analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.